Seeking Alpha

Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its...

Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its Levemir drug for pregnant women with diabetes after finding it did not increase the risk to unborn babies. NVO says it's now "the only company that offers a complete portfolio of insulin analogs" with this approval.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector